In addition to the mechanisms of action of TZ [30,36,37,38], T-DM1 exerts its anticancer activity through internalization in HER-2+ cancer cells, where the conjugated drug DM1 prevents the assembly of the mitotic spindle, leading to cell cycle arrest. The gene discussed is ERBB2; the disease is cancer.